Investors bought shares of Monsanto (NYSE:MON) on weakness during trading on Monday. $108.49 million flowed into the stock on the tick-up and $34.36 million flowed out of the stock on the tick-down, for a money net flow of $74.13 million into the stock. Of all stocks tracked, Monsanto had the 3rd highest net in-flow for the day. Monsanto traded down ($0.36) for the day and closed at $123.15
Several equities research analysts have recently issued reports on MON shares. Zacks Investment Research downgraded shares of Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, December 11th. Wells Fargo & Co reissued a “market perform” rating and set a $128.00 price objective (up previously from $118.00) on shares of Monsanto in a research report on Wednesday, January 17th. Deutsche Bank reissued a “buy” rating on shares of Monsanto in a research report on Tuesday, January 16th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $128.00 price objective on shares of Monsanto in a research report on Wednesday, November 15th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $127.30.
The company has a market capitalization of $54,480.00, a PE ratio of 22.84, a price-to-earnings-growth ratio of 1.77 and a beta of 0.95. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05.
Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). The business had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm’s revenue for the quarter was up .3% on a year-over-year basis. During the same period last year, the business posted $0.21 EPS. equities research analysts predict that Monsanto will post 5.76 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be given a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date of this dividend is Thursday, April 5th. Monsanto’s dividend payout ratio (DPR) is currently 39.93%.
In related news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.70% of the stock is currently owned by company insiders.
Institutional investors have recently added to or reduced their stakes in the stock. Gradient Investments LLC acquired a new stake in Monsanto in the fourth quarter valued at $108,000. Americafirst Capital Management LLC acquired a new stake in Monsanto in the third quarter valued at $148,000. Elkfork Partners LLC acquired a new stake in Monsanto in the fourth quarter valued at $162,000. Truewealth LLC acquired a new stake in Monsanto in the fourth quarter valued at $163,000. Finally, Flinton Capital Management LLC lifted its stake in Monsanto by 90.9% in the fourth quarter. Flinton Capital Management LLC now owns 1,764 shares of the basic materials company’s stock valued at $206,000 after acquiring an additional 840 shares during the last quarter. 76.25% of the stock is owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Investors Buy Monsanto (MON) on Weakness” was posted by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://ledgergazette.com/2018/03/14/investors-buy-monsanto-mon-on-weakness.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.